CannabisNewsWire
CannabisNewsWire

News and publishing service
for cannabis related companies

LimeLight of The week is

XPhyto Therapeutics Corp.
(CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT)

View The Complete Profile

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) is a bioscience accelerator focused on next-generation drug delivery, diagnostic and new active pharmaceutical ingredient investment opportunities. This includes products that are being readied for commercialization within the coming weeks, such as a rapid COVID-19 PCR test kit that reduces turnaround times to less than 30 minutes.

The company has research and development operations in North America and Europe and an operational focus in Germany. Its regulatory approval and commercialization focus is currently on products for the European market.

XPhyto was founded in 2017 and is headquartered in Vancouver, British Columbia.

Investment Considerations

  • XPhyto Therapeutics Corp. is a bioscience accelerator focused on next-generation drug delivery, diagnostic and new active pharmaceutical ingredient investment opportunities.
  • The company has research and development operations in North America and Europe and an operational focus in Germany.
  • XPhyto’s operations are concentrated into three core divisions: infectious disease diagnostics, clinical development of transdermal and sublingual drug formulations, and psychedelic medicine.
  • The company’s lead diagnostic product is an accurate, rapid and highly portable PCR diagnostic test system being evaluated in Europe for the detection of COVID-19.
  • XPhyto’s German subsidiary, Vektor Pharma TF GmbH, is advancing four therapeutic programs targeting neurological indications; the company intends to complete human pilot studies evaluating these products in 2021.
  • The company has two agreements in place focused on psychedelic compounds, a promising new class of API with strong potential for the treatment of mental health conditions.
View More

Receive SMS Text Alerts from CannabisNewsWire

Text "Cannabis" to 21000

(US Mobile Phones Only)

Featured Event

Cannabis World Congress & Business Exposition
New York City
5/27/21 to 5/29/21


The Cannabis World Congress & Business Exposition (CWCBExpo) is a business-to-business trade show event for the legalized cannabis industry. It is held in the largest media, financial, and business markets. It is the leading forum for dispensary owners, growers, suppliers, investors, medical professionals, government regulators, legal counsel, and entrepreneurs looking to achieve business success and identify new areas of growth in this dynamic and fast-growing industry.

Continue


Upcoming Events

View All Conferences

About CannabisNewsWire (CNW)

CannabisNewsWire (CNW) is a multifaceted financial news and publishing company that delivers a new generation of social communication solutions, news aggregation and syndication, and enhanced news release services. Leveraging a professional team of journalists and writers, CNW introduces private and public companies to a wide audience of investors, consumers, journalists and the general public via social media and a rapidly expanding network of over 5,000 key distribution outlets. Cutting through information overload, CNW's innovative and proprietary systems clearly and succinctly deliver its clients much needed visibility, recognition and brand awareness. CNW is where news, content and information converge.

Stay Informed
We will be posting information about the presenting companies as they take the stage.

See The Latest

Connect With Us
Follow us on social media for the latest news and information from our network of brands and clients.

follow us on twitter  meet on linkedin  like us on facebook

CannabisNewsWire

CannabisNewsWire
303 S Broadway, Denver, CO 80209 (303) 498-7722


Copyright © 2019. All Rights Reserved.